THIS SITE IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY

Prescribing information and adverse event reporting statement can be found in the footer

London Neurodevelopmental Disorders Study Day

Watch our London Neurodevelopmental Disorders Study Day on demand now. We were joined by the following speakers: Dr Carsten Vogt, Dr Gayatri Omkar, Dr Moneesha Bhargava and Professor Raja Mukherjee. They discussed the treatment options available for the management of ADHD, the impact of COVID on ADHD assessments, looked at the range of approaches for effective management of sleep difficulties, and more.

This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is intended for UK healthcare professionals.

Your certificate will be available in your account once you have watched the on-demand video.

Login to get full access to this resource

Agenda

The Impact of COVID on the Management of ADHD Diagnostic Assessments in West Kent Community Paediatric Service (KCHFT)
Dr Gayatri Omkar, Consultant Community Paediatrician, ADHD Lead North and West Kent, Kent Community Health Foundation Trust.
Dr Moneesha Bhargava, Associate Specialist in Community Paediatrics, North and West Kent, Kent Community Health Foundation Trust.
The Treatment of ADHD in Patients with Comorbid Conditions, including Foetal Alcohol Spectrum Disorder (FASD)
Prof Raja Mukherjee, Consultant Psychiatrist, AMD LD, Clinical Lead Adult NDD & FASD, Foetal Alcohol Spectrum Disorders Service, Surrey and Borders Partnership NHS Foundation Trust; Honorary Professor University of Salford; Visiting Professor, University of Surrey; Honorary Fellow University of Western Australia.
The Perils of Poor Sleep: Treatment Approaches in Children with Autism and Intellectual Disabilities
Dr Ashley Liew, Consultant Paediatric Neuropsychiatrist, Evelina London Children’s Hospital and South London & Maudsley NHS Foundation Trust; Honorary Associate Professor, University of Warwick.
Measuring Stimulant Treatment Response Using Objective Measurements for Patients with ADHD
Dr Carsten Vogt, Consultant Child & Adolescent Psychiatrist, Children, Young Persons and Families Berkshire.

Learning Objectives

  • To review the impact of COVID on ADHD assessments and the resulting service improvements made within a community paediatric setting
  • To explore the diagnosis and management of ADHD and comorbid conditions including Foetal Alcohol Spectrum Disorders (FASD)
  • To look at a range of approaches for the effective management of sleep difficulties in young people with neurodevelopmental disorders
  • To examine the efficacy of ADHD treatments for children and young people using objective measures

Related Resources